Clinical Trial Update: Metabolic Consequences of CPT-1 Deficiency [NA]

View source ↗

Summary

Clinical trial investigating the metabolic consequences of CPT-1A deficiency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carnitine Palmitoyltransferase Deficiency

Snippet

Sponsor: Oregon Health and Science University | Conditions: Carnitine Palmitoyl Transferase Type 1A (CPT1A) Deficiency | NA | Status: COMPLETED